Monthly Archives: March 2012

Engaging the private sector to spur global development and save the foreign assistance budget

By on .

Foreign assistance experts gathered Wednesday to discuss the George W. Bush administration’s legacy on global development, focusing on lessons learned and applying them to the next decade and beyond, at an event hosted by the Consensus for Development Reform and the Modernizing Foreign Assistance Network in Washington. The panel discussion revolved around a central theme […]

Report shows $1.37 billion gap in R&D funding needed to eliminate TB by 2050

By on .

TB research and development investment increased 76 percent between 2005 and 2010, but investment has slowed markedly, with only 2 percent growth since 2009. The $630.4 million 2010 investment is only one-third of the $2 billion needed to stay on track with the Global Plan to Stop TB 10-year implementation and research strategy to eliminate […]

World TB Day roundup

By on .

This special edition of What We’re Reading highlights reports and commentary released around World TB Day (Saturday, March 24, 2012). No More Crying, No More Dying. Towards Zero TB Deaths in Children: This issue brief from the Stop TB Partnership and the World Health Organization calls on public health programs and health care providers to […]

Global health community applauds nomination of Dr. Jim Kim for World Bank president

By on .

Much to the delight of global and domestic HIV/AIDs and tuberculosis (TB) advocates, President Obama announced Friday his nomination of Jim Yong Kim, MD, PhD, for the post of president of the World Bank. Kim has served Dartmouth College president since 2009. “Jim has spent more than two decades working to improve conditions in developing […]

USAID Administrator Shah meets with TB advocates; announces two new centers

By on .

The head of the U.S. Agency for International Development (USAID), Dr. Rajiv Shah met with tuberculosis (TB) advocates from various organizations Friday, the day before World TB Day. The group discussed how to do more to combat TB disease in a time of shrinking budgets, when USAID’s support is needed to push several key TB […]

Journals give access to TB articles

By on .

To commemorate World TB Day, the editors of Clinical Infectious Diseases and the Journal of Infectious Diseases have made various articles about tuberculosis freely available until the end of March.  Topics range from recent advances in TB diagnostics, to new TB drugs, to how smoking affects TB susceptibility. Both journals are publications of the Infectious […]

Fail to Scale: the cost of thinking small in fight against TB

By on .

The following is a guest blog post by John Fawcett, Legislative Director for RESULTS, who writes in advance of World TB Day (Saturday, March 24).

In 2008, Congress passed the Tom Lantos and Henry J. Hyde United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act with strong bipartisan support…

Advocates announce Civil Society Declaration on TB in Africa

By on .

At an event commemorating World TB Day on Tuesday at PATH, the organization’s TB Team Leader D’Arcy Richardson reminded the audience of some lesser-known facts about the human toll of tuberculosis throughout the world: TB created 9.7 million orphans in 2009 alone; TB kills more women worldwide than all other causes of maternal mortality combined; […]

House launches TB Elimination Caucus

By on .

Rep. Eliot Engel (D-NY) made a brief appearance Tuesday at a Congressional briefing, hosted by several TB advocacy organizations, highlighting tuberculosis and its continuation as a global health threat. He called the fact that TB hasn’t been eradicated “a sin,” and then briefly announced the newly formed U.S. House of Representatives TB Elimination Caucus – […]

Top private funder of TB R&D moves forward with trials of promising new drug

By on .

Otsuka Pharmaceuticals is the top private funder of tuberculosis (TB) research and drug development in the world. Last year, Otsuka established a Geneva-based subsidiary – Otsuka SA – to serve as “the company’s central operations for developing and implementing public health policies and corporate social responsibility programs in connection with its global TB program,” according to the company’s website.

As part of our reporting in advance of World TB Day on Saturday (March 24), Science Speaks interviewed Patrizia Carlevaro, PhD, the leader of Otsuka SA, to discuss Otsuka’s latest research to address drug-resistant forms of TB, the world’s emerging tuberculosis “hotspots,” and other efforts by the subsidiary organization to tackle TB.